Innate Immunity and its integration in Autoimmune Disease of the Eye
Innate Immunity and its integration in Autoimmune Disease of the Eye
批准号:
9041596
负责人:
HOLLY Lallman ROSENZWEIG
金额:
$28.35万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-04-01 至 2019-02-28
关键词:
AddressAntibodiesAntibody FormationAntigen-Antibody ComplexAntigensArthritisAutoimmune DiseasesAutoimmune ResponsesAutoimmunityBone MarrowCellsChimera organismChronicComplementComplexCuesDataDepositionDermatitisDevelopmentDiseaseDisease modelEffector CellEvaluationEventEyeFamilyGene ExpressionGenesGeneticGenetic Predisposition to DiseaseGoalsGrantGranulomatousHealthHomeostasisHost DefenseHumanHypersensitivityITGAM geneIgG ReceptorsImmuneImmune System DiseasesImmune responseImmunoglobulin GImmunologic ReceptorsInfiltrationInflammationInflammatoryInnovative TherapyInterleukin-17InvadedKnockout MiceLeadLightLinkMediatingMedicalMicrogliaMusMutationNatural ImmunityOutcomePathogenesisPathogenicityPathologyPathway interactionsPatientsPenetrancePhysiologicalPoint MutationPopulationProductionReactionReceptor ActivationReceptor GeneRecruitment ActivityRegulationRepressionRetinaRetinalRoleSyndromeSystemT cell regulationT-LymphocyteTestingTherapeuticTherapeutic InterventionTissuesToll-like receptorsUpdateUveitisVasculitisVisionadaptive immunityautoimmune uveitisautoinflammatoryautoreactive T cellbasebehavior influencecomplement systemgene discoveryin vivoinsightinterstitial retinol-binding proteinmacrophagemicrobialmolecular pathologynovelnovel strategiesnovel therapeuticspathogenpreventprogramsreceptorresearch studyresponsesensortherapy design
中文摘要
描述(申请人提供):先天免疫,作为抵御微生物病原体的第一道防线,是一种必须严格监管的反应,否则会接踵而至的过度炎症,导致疾病。对于最佳的治疗方法,我们不仅需要了解导致疾病的启动和早期事件的基本机制,而且重要的是,身体如何保护自己免受可能触发自身免疫的异常免疫反应的影响。葡萄膜炎(眼内炎症)是一种与许多系统性免疫疾病相关的疾病,由于对其发病机制的不完全了解,对医学提出了相当大的挑战。NOD2基因可能会为葡萄膜炎提供重要线索,因为单点突变会导致一种罕见的炎症性疾病,称为BLAU综合征,表现为肉芽肿性葡萄膜炎。NOD2属于天然免疫受体家族,称为NOD样受体(NLRs),是参与宿主防御入侵病原体的细胞内感受器。由于没有其他单一基因被确定为葡萄膜炎的单一原因,对NOD2通路的分析可以为控制眼部炎症的潜在机制提供重要的洞察。为了了解内源性、先天免疫受体NOD2如何参与自身免疫反应的协调,我们利用实验性自身免疫性葡萄膜炎(EAU)进行了研究,EAU是一种典型的T细胞介导的眼睛自身免疫性疾病模型。我们的初步研究使我们发现了一个意想不到的发现,即NOD2缺乏会使小鼠对EAU易感,从而确定NOD2是自身免疫性葡萄膜炎的主要遗传易感因素。这项赠款中概述的目标将检验这一建议的中心假设,即NOD2通过以下方式防止易导致自身免疫性疾病的异常反应,从而对维持眼睛免疫稳态非常重要:(1)保持T细胞效应器反应的适当调节,并转移致病的Th17效应器反应;(2)通过控制小胶质细胞的生理状态来解释眼睛内的微环境线索;以及(3)最大限度地减少涉及Fc-Gamma受体(FcgR)和抗体相关激活背景下的补体系统的超敏反应造成的组织损害。这个项目的目标是解决目前该领域中与先天免疫受体的影响和自身反应性T细胞驱动的反应的协调有关的未回答的问题。通过关注NOD2如何控制存在于先天免疫和获得性免疫交界处的早期和先天反应,我们希望找到方法来增强眼睛内的保护性先天防御,同时避免炎症病理的不良适应效应,作为一种潜在的新策略,用于葡萄膜炎和其他潜在威胁视力的疾病的治疗干预。
英文摘要
DESCRIPTION (provided by applicant): Innate immunity, as the first line of defense against microbial pathogens, is a response that must be tightly regulated or excessive inflammation will ensue, causing disease. For an optimal therapeutic approach, we need to not only understand basic mechanisms of initiation and early events that lead to disease but importantly, how the body protects itself from aberrant immune responses that can trigger autoimmunity. Uveitis (intraocular inflammation), which occurs in association with a number of systemic immunological diseases, presents a considerable medical challenge due to incomplete understanding of its pathogenesis. The gene NOD2 may provide an important clue into uveitis because a single point mutation results in a rare, inflammatory disease called Blau syndrome, which manifests as granulomatous uveitis. NOD2 belongs to a family of innate immune receptors termed NOD-like receptors (NLRs), which are intracellular sensors involved in host defense against invading pathogens. Since no other single gene has been identified as a singular cause of uveitis, analysis of NOD2-pathways could offer important insight into the underlying mechanisms controlling ocular inflammation. To understand how the endogenous, innate immune receptor NOD2 participates in orchestration of autoimmune responses, we undertook studies using experimental autoimmune uveitis (EAU), a prototypical T cell-mediated autoimmune disease model of the eye. Our preliminary studies led us to the unanticipated discovery that NOD2 deficiency renders mice susceptible to EAU; thereby identifying NOD2 as a major genetic susceptibility factor in autoimmune uveitis. Objectives outlined in this grant will test the centra hypothesis of this proposal that NOD2 is important for maintaining ocular immunological homeostasis by preventing aberrant responses that predispose to autoimmune disease of the eye by: (1) Maintaining proper regulation of T cell effector responses and diverting a pathogenic Th17-effector response; (2) Interpreting microenvironment cues within the eye by controlling the physiological state of microglia; and (3) Minimizing tissue damage caused by hypersensitivity responses involving the Fc-gamma receptor (FcgR) and complement systems that occur in the context of antibody-related activation. The goal of this project is to address currently unanswered questions within the field pertaining to the influence of innate immune receptors and orchestration of autoreactive T cell-driven responses. By focusing on aspects of how NOD2 controls early and innate reactions that exist at the interface of innate and adaptive immunity we hope to identify ways to enhance protective innate defenses within the eye while avoiding maladaptive effects of inflammatory pathology, as a potential novel strategy for therapeutic intervention for uveitis and other potentially vision-threatening diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Back to Basics: T Cellular Control of Nod2 in Uveitis
-
批准号:10615007
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2015
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
Back to Basics: T Cellular Control of Nod2 in Uveitis
-
批准号:10396089
-
项目类别:
-
资助金额:$30.56万
-
财政年份:2015
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
Monarch/NLRP12: A Newly discovered Innate Immune Receptor in Uveitis
-
批准号:8969545
-
项目类别:
-
资助金额:$18.9万
-
财政年份:2015
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
Back to Basics: T Cellular Control of Nod2 in Uveitis
-
批准号:10210400
-
项目类别:
-
资助金额:$30.56万
-
财政年份:2015
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
Innate Immunity and its integration in Autoimmune Disease of the Eye
-
批准号:8860023
-
项目类别:
-
资助金额:$28.07万
-
财政年份:2015
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
Interaction of environment and genetics in the predisposition to inflammatory art
-
批准号:8633790
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
Interaction of environment and genetics in the predisposition to inflammatory art
-
批准号:8974337
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
NOD2 and Uveitis
-
批准号:8306860
-
项目类别:
-
资助金额:$36.59万
-
财政年份:2009
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
NOD2 and Uveitis
-
批准号:8114023
-
项目类别:
-
资助金额:$36.59万
-
财政年份:2009
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
NOD2 and Uveitis
-
批准号:7730112
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2009
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
NOD2 and Uveitis
-
批准号:7904152
-
项目类别:
-
资助金额:$38.12万
-
财政年份:2009
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
Investigation of Nod2: Implications for Uveitis
-
批准号:7344682
-
项目类别:
-
资助金额:$4.88万
-
财政年份:2006
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
Investigation of Nod2: Implications for Uveitis
-
批准号:7188554
-
项目类别:
-
资助金额:$4.6万
-
财政年份:2006
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
Investigation of Nod2: Implications for Uveitis
-
批准号:7053939
-
项目类别:
-
资助金额:$4.4万
-
财政年份:2006
-
负责人:HOLLY Lallman ROSENZWEIG
-
依托单位:
海外基金